OptimizeRx | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
OptimizeRx | 8-K: OptimizeRx Reports Second Quarter 2024 Financial Results
OptimizeRx | S-8 POS: S-8 POS
OptimizeRx | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
OptimizeRx | 8-K: Current report
OptimizeRx | 8-K: OptimizeRx Reports First Quarter 2024 Financial Results
OptimizeRx | 8-K: Current report
OptimizeRx | DEF 14A: Definitive information statements
OptimizeRx | 8-K: OptimizeRx Reports Strong Fourth Quarter a nd Full Year 2023 Financial Results
OptimizeRx | 8-K: Current report
OptimizeRx | NT 10-K: Others
OptimizeRx | 8-K: Current report
OptimizeRx | 8-K: Current report
OptimizeRx | 8-K/A: Current report (Amendment)
OptimizeRx | 8-K: OptimizeRx Reports Third Quarter 2023 Financial Results
OptimizeRx | 8-K: Current report
OptimizeRx | 8-K: Current report
OptimizeRx | 8-K: OptimizeRx Reports Second Quarter 2023 Financial Results
OptimizeRx | 8-K: Current report
OptimizeRx | 8-K: OptimizeRx Reports First Quarter 2023 Financial Results
No Data
No Data